Pharming Group N.V. confirms it will announce financial results for the nine months ended September 30, 2022 on Thursday, October 27, 2022.

Pharming Group N.V. presents its preliminary (unaudited) financial report for the first six months of 2022 ended June 30, 2022.

Pharming confirms it will announce financial results for the six months ended 30 June 2022 on Thursday, August 4, 2022.

Pharming Group N.V. presents its (unaudited) financial report for the first quarter of the year ended 31 March 2022.

Pharming confirms it will announce financial results for the first quarter of the year ended 31 March 2022 on Thursday, 12 May 2022.

Following an agreed investment by European investment company Gimv, Pharming’s minority stake of 43.85% in BioConnection will reduce to 22.98%. As a result of this transaction, Pharming will receive one-off US$ 7.5 million (EUR 6.9 million) net cash proceeds.

Pharming Group presents its preliminary financial report for the full year ended December 31, 2021.

Pharming Group presents its preliminary (unaudited) financial report for the first nine months ended September 30, 2021.

Recovery continued into Q2 2021 as patient enrollment and product demand increases